Product Description
Tinidazole, a synthetic imidazole derivative, has been used in the oral treatment of several protozoal infections - trichomoniasis, giardiasis and amoebiasis. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/954609/)
Mechanisms of Action: DNA Antagonist,DNA Synthesis Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Chile | China | Colombia | Cyprus | Dominican Republic | Ecuador | Egypt | France | Germany | Hungary | India | Ireland | Israel | Jordan | Korea | Latvia | Lebanon | Lithuania | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Singapore | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Taiwan | Tunisia | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|